1. Home /
  2. Biotechnology company /
  3. Cardea Bio Inc.

Category



General Information

Locality: San Diego, California



Address: 8969 Kenamar Dr. Suite 104 92121 San Diego, CA, US

Website: cardeabio.com/

Likes: 222

Reviews

Add review

Facebook Blog





Cardea Bio Inc. 21.02.2021

World CRISPR Day is tomorrow! Sign up for Cardea Bio Inc.'s virtual #webinar at 1:30 PM PDT to: Gain exclusive insight to how our Innovation Partnership Program is being made accessible to over 200 companies from a vast number of industries to develop a new generation of products and applications that can link computers up to the signals of LIVE biology Frustrated with time consuming and expensive #CRISPR quality controls? Cardea Innovation Partner, Crispr QC, will share ...how our CRISPR-Chips are being integrated into streamlined quality control instruments that help researchers save time and resources while accelerating performance and accuracy Win an Amazon Echo or Google Nest! All attendees will be given the chance to enter our raffle Sign up for the webinar here: https://zoom.us/webinar/register/WN_x2kcH5TTTLKaCcZwfcmd9Q

Cardea Bio Inc. 02.11.2020

Stop by our virtual booth at #CRISPR World day next Tuesday for an opportunity to talk to Dr. Francie Barron, VP of our Innovation Partnership Program, meet our innovation partner Crispr QC, and join our raffle at 1:30 PM! Make sure to also not miss 2020 Nobel Laureate in Chemistry Dr. Jennifer Doudna’s Keynote address at 8AM PT followed by Cardea CSO & Co-founder Dr. Kiana Aran at 11:30 AM PT sharing how Cardea’s technology is implemented into Innovation Partner, CRISPR QC’s CRISPR quality control instrument, CRISPR-BIND for rapid & sensitive testing without the need of amplification or labels . #WorldCRISPRDay #NobelPrize Register for the free event here: https://events.synthego.com/e/WorldCRISPRDay2020

Cardea Bio Inc. 21.10.2020

We’re excited to announce the formation of the Cardea #Innovation Council lead by Cardea’s Executive Chairman Paul Grint. We welcome Home Secretary of the U.S. National Academy of Sciences, professor Susan Wessler, #CRISPR pioneer Virginijus Siksnys, Recipient of IEEE Medal of Honor Dr. Kurt Petersen, experts in genomics Dr. Phil Cotter and Dr Lauge Farnaes, as well as leader in healthcare data analytics Dr. Elia Stupka as council members. https://cardeabio.com/crispr-pioneer-home-secretary-of-the/

Cardea Bio Inc. 14.10.2020

We’re one week away from the Synthego #CRISPR World Day conference with 2020 Nobel Laureate in Chemistry and Keynote Speaker, Dr. Jennifer Doudna! Cardea CSO & Co-founder, Dr. Kiana Aran, will be speaking at 11:30AM PT about the Biology of CRISPR Applications and how Cardea is empowering our latest Innovation Partner, Crispr QC, to develop rapid and sensitive automated CRISPR quality control instruments without the need of labels or amplification. #WorldCRISPRDay #NobelPrize Register for the talk here: https://events.synthego.com/e/WorldCRISPRDay2020#Agenda

Cardea Bio Inc. 11.10.2020

#COVID19 has brought the limitations of life science to solve problems into a global focus. Tune into our Co-founder and Chief Production Officer, Ross Bundy’s, SEMI webinar Opportunities in Biotech and Related Markets Due to COVID-19 to hear how Cardea’s Tech+Bio Infrastructure has created a fundamental paradigm shift in life science. Together with our Innovation Partners, we’re building a new generation of Powered by Cardea products and applications that will enable humanity to finally gain control over complex problems of health, environmental safety, food security and much more. Click on the link below to register! https://www.semi.org//events/mems-sensors-executive-congre #Innovation

Cardea Bio Inc. 05.10.2020

We're excited to today announce that we received a foundational key patent for our Graphene Transistor and Sensor Mass Production Processes! This is one of several fundamental patents empowering Cardea to be the first and only company to mass produce graphene transistors at commercial scale. https://cardeabio.com/cardea-bio-inc-receives-fundamental-/

Cardea Bio Inc. 30.09.2020

The discovery of #CRISPR has revolutionized the fields of transcriptional activation and repression, genome editing, gene-based therapeutics and diagnostics. With continuous discoveries of new Cas enzymes and modifications to gRNAs to efficiently direct them to their targets, quality control has never been as crucial as it is today. How will these enzymes react to for example temperature pr pH changes? Our Co-founder and CSO, Dr. Kiana Aran, will in her LabRoots, Inc. talk, discuss how our CRISPR-Chips are being used to power the Crispr QC tool, CRISPR-BIND: a rapid and highly sensitive platform to characterize guide RNA and CRISPR-Cas interactions. Learn more by clicking the link below: https://www.labroots.com/virtual-event/crispr-2020/agenda

Cardea Bio Inc. 13.09.2020

Want to be among the first to see how CRISPR-BIND can accelerate your CRISPR research? Apply to Crispr QC's Early Access Program! https://crisprqc.com/crispr-bind #CRISPR #Innovation #research

Cardea Bio Inc. 29.08.2020

If You're Changing the Code of Life - Get it Right! We're thrilled to announce the global launch of our first commercial "Powered by Cardea" product. Built upon Cardean Transistors, CRISPR QC is launching CRISPR-BIND, a fast and highly sensitive automated CRISPR quality control tool.

Cardea Bio Inc. 27.08.2020

Cardea Bio Announces $7.5M in First Close of Series A2 Financing. We welcome lead investors Tsingyuan, Lifespan Investments, and longtime support Serra Ventures, as well as Agilent and many others as new shareholders. We also want to thank our loyal existing shareholders for their continued support and trust in Cardea and our team of talents. This funding will be used to support the commercial launch of multiple Powered by Cardea product collaborations through our Innovation Partnership Program and to accelerate the growth of our Tech+Bio Infrastructure. https://www.prweb.com//cardea_bio_announ/prweb17402656.htm

Cardea Bio Inc. 15.08.2020

We’ve been recognized as a semifinalist for AACC’s 2020 Disruptive Technology Award! Thank you AACC for the recognition! #DisruptiveTechnology #2020AACC #Innovation https://meeting.aacc.org/confer/disruptive-technology-award

Cardea Bio Inc. 31.07.2020

A big congratulations to Dr. Kiana Aran, our Co-founder and CSO, for winning the 2020 #Pinnacle award in the Life Science category! #womeninstem https://www.athenasd.org/pinnacle-awards

Cardea Bio Inc. 20.07.2020

The #AMPT webinar is tomorrow! Don’t forget to register for the event to hear @Ross Bundy, Co-founder and Chief Production Officer of Cardea, discuss how our #CRISPR-Chip technology can be leveraged to develop a rapid #coronavirus handheld test device in the panel Advanced Material-enabled Commercial Solutions & Products for a Pandemic-free World at 9:05AM CDT. https://www.amptnetwork.com//vision-accelerator-event-july

Cardea Bio Inc. 08.07.2020

Can advanced materials, such as graphene, help the COVID-19 pandemic? Ross Bundy, Co-founder and Chief Production Officer of Cardea, will discuss how our #CRISPR-Chip technology can be leveraged to develop a rapid #coronavirus handheld test device in the panel Advanced Material-enabled Commercial Solutions & Products for a Pandemic-free World at 9:05AM CDT next Tuesday, July 28. Register to the #AMPT webinar below! https://www.amptnetwork.com//vision-accelerator-event-july